ECSP003464A - PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS - Google Patents
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONSInfo
- Publication number
- ECSP003464A ECSP003464A ECSP003464A ECSP003464A EC SP003464 A ECSP003464 A EC SP003464A EC SP003464 A ECSP003464 A EC SP003464A EC SP003464 A ECSP003464 A EC SP003464A
- Authority
- EC
- Ecuador
- Prior art keywords
- pharmaceutical composition
- treatment
- streptococcus pneumoniae
- pneumoniae infections
- prone
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 title 1
- -1 4- (4-chlorophenyl) benzyl Chemical group 0.000 abstract 1
- 108010053950 Teicoplanin Proteins 0.000 abstract 1
- DDTDNCYHLGRFBM-YZEKDTGTSA-N chembl2367892 Chemical compound CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@@H]([C@H]1C(N[C@@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(O)C=C(C=4)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@H](CC=4C=C(Cl)C(O5)=CC=4)C(=O)N3)C(=O)N1)C(O)=O)=O)C(C=C1Cl)=CC=C1OC1=C(O[C@H]3[C@H]([C@@H](O)[C@H](O)[C@H](CO)O3)NC(C)=O)C5=CC2=C1 DDTDNCYHLGRFBM-YZEKDTGTSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960001608 teicoplanin Drugs 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se sumistra una composición farmacéutica para uso en la fabricación de un medicamento para ser usado en la prevención a largo plazo de S. Pneumoniae en individuso propensos, en la cual al menos una dosis mensual de NDISSAC -(4-(4-clorofenil)bencil A82846B, teicoplanina, o mezclas de las mismas, es administrada a un individuo propenso.A pharmaceutical composition is supplied for use in the manufacture of a medicament for use in the long-term prevention of S. pneumoniae in prone individuals, in which at least one monthly dose of NDISSAC - (4- (4-chlorophenyl) benzyl A82846B, teicoplanin, or mixtures thereof, is administered to a prone individual.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP003464 ECSP003464A (en) | 2000-05-02 | 2000-05-02 | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP003464 ECSP003464A (en) | 2000-05-02 | 2000-05-02 | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003464A true ECSP003464A (en) | 2000-12-19 |
Family
ID=42041091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP003464 ECSP003464A (en) | 2000-05-02 | 2000-05-02 | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP003464A (en) |
-
2000
- 2000-05-02 EC ECSP003464 patent/ECSP003464A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP045102A (en) | Pharmaceutical formulation containing 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol and provides a delayed release of the active ingredient | |
ATE302616T1 (en) | MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS | |
BRPI0415649A (en) | method for treating, preventing, modifying or administering pain and pharmaceutical composition | |
AR032556A1 (en) | IMMEDIATE ACTION DRUG FOR THE TREATMENT OF SEXUAL DYSFUNCTION | |
BRPI0113331B8 (en) | phenylalanine derivatives or their pharmaceutically acceptable salts, alpha 4 integrin antagonist, therapeutic agent or preventive agent for inflammatory diseases, and pharmaceutical composition | |
BR0014383A (en) | Controlled release compositions comprising nimesulide | |
AR018862A1 (en) | PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE, IMPROVED FOR THE ORAL ADMINISTRATION OF NEFAZODONA OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; ORAL DOSAGE FORM THAT UNDERSTANDS AND USE OF SUCH FORMULATION TO PREPARE THE SUCH DOSAGE FORM | |
DE50203456D1 (en) | DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS | |
AR034517A1 (en) | PHARMACEUTICAL FORMULATION | |
BR0112847A (en) | Use of a solid dosage form | |
EE200300064A (en) | Pharmaceutical composition for the treatment and / or prevention of C. pneumoniae infections, organic composition and their use | |
ATE464878T1 (en) | PHARMACEUTICAL COMPOSITION FOR NASAL USE OF FENTANYL | |
UY27416A1 (en) | USE OF BIBN4096 IN COMBINATION WITH OTHER ANTIMIGRANOSE DRUGS FOR THE TREATMENT OF MIGRANA | |
BRPI0412430A (en) | zot and zonulin receptor agonist polypeptide | |
SE0001916D0 (en) | Novel formulation | |
AR048318A1 (en) | ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA | |
AR041573A1 (en) | USE OF HYDROMIDAZOLONES FOR THE PREPARATION OF MEDICATIONS FOR CANINOS | |
ECSP003464A (en) | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS | |
AR037496A1 (en) | NOVEDOUS USE OF 2- [5- (4-FLUOROPHENYL) -3-PIRIDILMETILAMINOMETIL] -CROMANO AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS | |
BR0210632A (en) | Parasitic disease treatment | |
HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
SE0000303D0 (en) | Novel compounds | |
SV2002000065A (en) | MONTHLY DOSE FOR THE TREATMENT OF INFECTIONS BY STREPTOCOCCUS PNEUMONIAE REF. X-12423 | |
SE0203817D0 (en) | New composition | |
AR045074A1 (en) | USE OF CD164 SOLUBLE IN INFLAMMATORY AND AUTO-IMMUNE DISORDERS |